INVO Bioscience, Inc. (NASDAQ:INVO – Get Rating) was the target of a large decline in short interest in the month of February. As of February 15th, there was short interest totalling 42,200 shares, a decline of 44.2% from the January 31st total of 75,600 shares. Based on an average trading volume of 43,700 shares, the […]
Chicoâs FAS Inc. (NYSE: CHS)Â
Phunware Inc. (NASDAQ: PHUN)Â Invo Bioscience Inc.Â
Shares of the biotech company shot up late in the session on Monday. Before we get into why letâs take a closer look at Invo Bioscience. The company produces medical devices used in the treatment of infertility in women. This includes its INVO Procedure, which is a more natural way to perform incubation. Its leading product, known as INVOcell, is a patented device known as an Assisted Reproductive Technology or ART. It is an intravaginal culture system and can inseminate eggs for embryo development. This is an alternative to traditional in-vivo procedures and can be much more cost-effective and available for patients.